MedTrace Logo

Prognosis of Extremely Premature Birth

NCT01150396 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 160

Last updated 2015-06-02

No results posted yet for this study

Summary

Pregnant women at risk of giving birth before 28 weeks' gestational age will be enrolled. Fetal circulation will be studied and blood for inflammatory parameters will be collected. If birth occurs before 28 weeks, detailed information on clinical course of the newborn until discharge from the neonatal intensive care unit will be recorded,and specimens of amniotic fluid, placenta, blood and urine will be collection for inflammatory parameters. After discharge the children will be followed according to a specific protocol until 5 years of age.

Conditions

  • Infant, Premature, Diseases
  • Perinatal Morbidity
  • Development
  • Problem;Growth

Sponsors & Collaborators

  • Haukeland University Hospital

    collaborator OTHER

  • Helse Stavanger HF

    collaborator OTHER_GOV

  • University of Bergen

    lead OTHER

Principal Investigators

  • Trond Markestad, MD, PhD · University of Bergen, Faculty of Medicine

Eligibility

Min Age
22 Weeks
Max Age
27 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-07-31
Primary Completion
2017-12-31
Completion
2018-12-31

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01150396 on ClinicalTrials.gov